Literature DB >> 28763837

[The treatment of early-stage liver cancer].

X D Zhu1, H C Sun.   

Abstract

Although the diagnostic rate of early-stage liver cancer is low, only these patients have a chance of radical treatment, and thus related treatment modalities deserve attention. Surgical resection is the preferred choice for the treatment of early-stage liver cancer. For patients with high selectivity, local treatment including radiofrequency ablation can achieve satisfactory outcomes. Liver transplantation is the preferred choice for patients with decompensated liver cirrhosis. Early-stage liver cancer has a high postoperative recurrence rate, and the research and development of postoperative adjuvant therapy should be taken seriously.

Entities:  

Keywords:  Carcinoma, hepatocellular; Locoreginal therapy; Operation; Treatment

Mesh:

Year:  2017        PMID: 28763837     DOI: 10.3760/cma.j.issn.1007-3418.2017.05.004

Source DB:  PubMed          Journal:  Zhonghua Gan Zang Bing Za Zhi        ISSN: 1007-3418


  1 in total

1.  LINC00922 promotes the proliferation, migration, invasion and EMT process of liver cancer cells by regulating miR-424-5p/ARK5.

Authors:  Zhiyu Ye; Qikuan He; Qiaona Wang; Yunshou Lin; Kenan Cen; Xiaogang Chen
Journal:  Mol Cell Biochem       Date:  2021-06-07       Impact factor: 3.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.